Cancer is a frightful disease and represents one of the biggest health-care issues for the human race and demands a proactive strategy for cure. Plants are reservoirs for novel chemical entities and provide a promising line for research on cancer. Hitherto, being effective, chemotherapy is accompanied by certain unbearable side effects. Nevertheless, plants and plant derived products is a revolutionizing field as these are Simple, safer, ecofriendly, low-cost, fast, and less toxic as compared with conventional treatment methods. Phytochemicals are selective in their functions and acts specifically on tumor cells without affecting normal cells. Carcinogenesis is complex phenomena that involves many signaling cascades. Phytochemicals are considered suitable candidates for anticancer drug development due to their pleiotropic actions on target events with multiple manners. The research is in progress for developing potential candidates (those can block or slow down the growth of cancer cells without any side effects) from these phytochemicals. Many phytochemicals and their derived analogs have been identified as potential candidates for anticancer therapy. Effort has been made through this comprehensive review to highlight the recent developments and milestones achieved in cancer therapies using phytomolecules with their mechanism of action on nuclear and cellular factors. Furthermore, drugs for cancer treatment and their limitations have also been discussed.
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Cancer: a global menace
Cancer is a severe metabolic syndrome and is one of the leading cause of death regardless of developments in the tools of disease diagnosis, treatment and prevention measures [1] [2] [3] . Cancer is one of the principal causes of mortality and morbidity around the globe and the number of cases are constantly increasing estimated to be 21 million by 2030 [4, 5] . It is estimated that in 2017, the United States alone will have approximately 1 688 780 new cancer diagnoses cases and 600 920 cancer deaths [6] . This uncontrolled proliferation of a normal cell which produces genetic instabilities and alterations accumulates within cells and tissues which transforms normal cell into a malignant cell. These genetic instabilities include mutations in DNA repair genes (p21, p22, p27, p51, p53 and tool box for DNA), tumor suppressor genes (p53, NF1, NF2, RB and biological breaks), oncogenes [MYC, RAF, Bcl-2, RAS (biological accelerators)] and genes involve in cell growth metabolism. Both external factors (radiations, smoking, tobacco, pollutants in drinking water, food, air, chemicals, certain metals and infectious agents) and internal factors (genetic mutations, body immune system and hormonal disorders) can cause cancer [7] . There are several types of cancer in human being; among these the lung cancer is reported the top listed in male followed by breast cancer in female [8, 9] . Detailed information about several forms of cancer is given in Table 1 . It is a major public health burden in both developing and developed countries being treated by medicinal plants as a whole or by their phytochemicals very frequently [10, 11] .
Previously, around 10.9 million new cancer cases, 24.6 million persons living with cancer, 6.7 million deaths reported around the world each year [12] . Based on World Health Organization data, above 14.1 million new cancer cases and 8.2 million deaths were mentioned globally in the year 2012 and over 70% new cancer cases has been estimated during the next twenty years [13] [14] [15] . Nearly, 80% of the world's population depend on traditional medicines and more than 60% of clinically approved anticancer drugs are derivatives of these medicinal plant [16, 17] . According to literature survey, there are many anticancer drugs clinically approved and are recommended for the cancer treatment [18, 19] .
Among these different forms of cancer, lung cancer is reported the most in male followed by breast cancer in female. The information is gathered from the cancer stat facts (https://seer. cancer.gov/statfacts/more.html) and cancer statistics (2017) by Siegel.
Drugs for cancer treatment and their limitations
A large number of efforts have been made to minimize the harmful side effects of drugs during the process of cancer therapy like preventing the side effects on the nearby cells and tissues, increasing drug accumulation and efficacy in the lesion, developing novel drug delivery and targeting systems [20] . There are so many other methods for the treatment of cancer like they involve surgery of tumor, radiotherapy, immunotherapy, chemotherapy, cancer vaccinations, photodynamic therapy, stem cell transformation or combination thereof often accompanied by severe side effects. Such side effects include limited bioavailability, toxicity, nonspecificity, fast clearance and restriction in metastasis [21, 22] . Treatment methods depend upon the cancer type, stage and location. Chemotherapeutic agents involve cytostatic and cytotoxic drugs which have shown promising results alone or in combination with other cancer therapies. These chemotherapeutic agents involve topoisomerase inhibitors [e.g. irinotecan (side effects include: neutropenia, sensory neuropathy, and diarrhoea) and doxorubicin (side effects include cardiotoxicity), alkylating agents e.g. oxaliplatin, melphalan, carboplatin, cisplatin and cyclophosphamide (side effects include: nephrotoxicity, gastrointestinal toxicity, cardiovascular toxicity, pulmonary and hematologictoxicity), microtubules acting agent e.g. vincristine, vinblastine, docetaxel and paclitaxel etc.] [18, 23] . The above mentioned drugs are highly effective against a wide range of cancers, but these drugs are also having some limitations (side effects, expensive, very complex, not ecofriendly and toxic). There are cells in our body which multiply rapidly under normal physiological conditions like hair follicle cells, bone marrow cells and digestive tract cells etc., These present anticancer drugs also target these rapidly dividing normal cells which is a big challenge thus, harmful side effects arise. Due to these side effects there is decreased blood production, GIT inflammation, hair loss, immunosuppression, heart diseases and nervous disorders may arise. Another limitation is that these cancer cells resist to these drugs as they go through mutations. e.g., Drug resistant genes (ABCA4 and ABCA12) were over-expressed in human MCF-7 breast cancer cells respectively when docetaxel was applied. However, when phytochemical curcumin was applied in association with docetaxel down regulation of drug resistance genes was observed [24] . Thus, treating cancer cells by employing mono-target chemical agent is not an effective method. Therefore, based on extensive research findings, phytochemicals and their derived analogues possess most promising option for the better and less toxic cancer treatment [19] .
Current cancer therapy via phytochemicals: a novel approach
Medicinal plants serve as nature's gift to humans to help them pursue better health. Plants and their bioactive compounds are in medicinal practices since ancient times. Several medicinal plant species and their phytochemicals inhibit the progression and development of cancer [24] . It has been researched that plant kingdom comprised of approximately 250 000 plant species and only around 10% have been studied for treatment of different diseases. Phytochemicals and their derived analogues are present in different parts of the plant, e.g., flower, flower stigmas, pericarp, sprouts, fruits, seeds, roots, rhizomes, stem, leaf, embryo, bark and perform several pharmacological functions. Several plant products such as alkaloids, flavonoids, lignans, saponins, terpenes, taxanes, vitamins, minerals, glycosides, gums, oils, biomolecules and other primary and secondary metabolites play significant roles in either inhibiting cancer cell activating proteins, enzymes and signaling pathways [Cdc2, CDK2 and CDK4 kinases, topoisomerase enzyme, cycloxigenase and COX-2 (Cycloxigenase), Bcl-2, cytokines, PI3K, Akt, MAPK/ERK, MMP, TNK, mechanistic target of rapamycin (mTOR) (detailed information in Figure 1 )] or by activating DNA repair mechanism (p21, p27, p51, p53 genes and their protein products), Bax, Bid, Bak proteins, stimulating the formation of protective enzymes (Caspase-3, 7, 8, 9, 10, 12), inducing antioxidant action (antioxidant enzymes Melanoma (Skin)  87 110  9 730  16  Testis cancer  8 850  410  17  Leukemia  62 130  25 500  18  Stomach cancer  28 000  10 960  19  Prostate cancer  161 360  26 730  20  Bone and joint  3 260  1 550  21  Breast cancer  252 710  40 610  22  Oral cavity & pharynx  49 670  9 700  23  Thyroid cancer  56 870  2 010  24  Pancreas cancer  53 670  43 090  25  Small intestine  10 190  1 390  26  Hodgkin lymphoma  8 260  1 070  27  Esophagus cancer  16 940  15 690  28  Myeloma  30 280  12 590 e.g. GSH, GST and GPxn), thus showing strong anticancer effects in terms of their efficacy on the above mentioned proteins, enzymes and signaling pathways (detailed information in Figure 2 ) [15, 25] . Detailed information about these medicinal plants, family, part used and specific type of anticancer phytochemical and their mechanism of action against particular type of cancer is given in Table 2 . Furthermore, the generalized model of carcinogenesis, anti-cancer mechanism of body and natural phytochemicals against cancer is discussed ( Figure 3 ). Literature for 2010-2017 was thoroughly reviewed from ISI web of knowledge. The results are given in Figure 4 .
Vinca alkaloids
Vinca alkaloids (VA) are a versatile group of phytochemicals isolated from Catharanthus roseus (C. roseus) (Apocynaceae) and are employed in the theraphy of several type of cancer namely, breast, liver, leukemia, testes lung cancer. The four main VA in use are, vinorelbine, vindesine, vincristine and vinblastine [158] . The vinca alkaloids (vincristine and vinblastine) bind a specific site termed as tubulin heterodimers (vinca-binding site) disrupting the functions of microtubules or by arresting cell cycle at metaphase [159] . Currently, semisynthetic derivatives of vinca alkaloids are vinorelbine, vindesine, vinfosiltine and vinovelbine which have been introduced in the market. These derivatives are used alone or in combination with other phytochemicals agents to fight against large number of cancers [160] . According to a scientific report, almost 64 cultivars of C. roseus were screened for vinca alkaloids where Cooler Rose Hot reported the highest level of serpentine alkaloids. In the near past, endophytic fungi cultured and isolated from C. roseus has been discovered as an alternative method for the production of the different vinca alkaloids [161] .
Taxanes
Taxanes represent promising anticancer agents that act by binding to microtubules and has key role in cell division [161] . First-generation taxanes (e.g. docetaxel and paclitaxel) are strong anticancer agents in terms of their efficacy on its different molecular targets. Paclitaxel (taxol) was first extracted from the bark and leaf of Taxus baccata (T. baccata) and T. canadensis, Corylus avellana and is used to cure a wide range of cancers including ovarian, breast and lung cancer. Binding of paclitaxel with b-tubulin in the lumen of microtubules leads to decrease in microtubule dynamics and halt cell cycle at M phase while docetaxel, a semi synthetic derivative from T. baccata is primarily used in breast, pancreas, prostate and lung cancers therapies [161, 162] . The primary mechanism of taxanes is to induce microtubule stabilization, apoptotic cell death and mitotic arrest [163] . Analogs of paclitaxel which are currently undergoing clinical trials include larotaxel, milataxel, ortataxel and tesetaxel. Larotaxel is used as alone or together with other therapies for urethral bladder, pancreatic, lung and breast cancer [164] . Furthermore, out of 2 069 cancer clinical trials documented by the National Cancer Institute as of July 2004, 248 are taxane-derived drugs, containing 134 with paclitaxel, 105 with docetaxel and 10 with miscellaneous taxanes are used either alone or together with other anticancer agents [97] . Taxanes (paclitaxel, docetaxel) and its nuclear and cellular targets are given in Figure 2 
Campothecin derivatives
Campothecin (family of topoisomerase I poisons) is another class of plant derived clinically-active chemotherapeutic agents possesses strong anticancer potential inhibiting topoisomerase I Figure 1 . Impact of anticancer phytochemicals after activating expression of various genes, proteins, enzymes and signaling cascades in order to block cancer initiation and progression.
in a large number of cancers [165] . It was first isolated from Camptotheca acuminata (Nyssaceae). The isolate of Camptotheca acuminata has been the only agent out of 1 000 different plant extracts screened out for anticancer activity which have shown efficacy and the active constituents isolated has been identified as camptothecin. Extensive research is performed by several research organizations for effective camptothecin derivatives like topotecan (hycamtin) and irinotecan, where irinotecan is used to treat colorectal cancer while topotecan is used to treat ovarian and lung cancer [166] .
Cephalotaxus
Cephalotaxus alkaloids are also a multipurpose group of phytochemicals that are used against wide range of cancer including A-549 lung cancer, HeLa, SGC-7901 gastric cancer cell lines. They function by inhibiting protein synthesis and targeting the molecular events in synthesis of protein such as initiation of protein synthesis, release of nascent peptide, polyribosome degradation but do not have any effect on elongation of new peptide chain [167] . Harringtonine and isoharringtonine cephalotaxus alkaloids are anticancer agents isolated from Cephalotaxus harringtonia. Anticancer agent like homoharringtonine has been researched to treat large number of cancers including chronic and acute myelogenous leukemia [168] .
In China, harringtonine in combination with homoharringtonine are successfully used for the treatment of chronic myelogenous leukemias, acute myelogenous leukemia [16] . The homoharringtonine also been approved by FDA for the treatment of chronic myelogenous leukemia in different countries around the world such as China, Japan, Pakistan, USA and Germany [169] .
Colchicine
Colchicine is a natural bioactive compound isolated from Colchicum autumnale (Colchicaceae) and has been researched to treat several diseases like crystal arthritis, cirrhosis, gout etc. It binds permanently to tubulin, stabilizes microtubule formation, arrest cell cycle at different phases and induces apoptosis [170] . Unluckily, colchicine's action is not very specific and targets rapidly dividing normal cells and arrest their cell cycle. Therefore, semisynthetic derivatives (colchicinamide, deacetylcolchicine) of colchicine have been developed which are less toxic and are used for the treatment of variety of cancers including colorectal (HCT-116), chronic granulocytic leukemia, melanoma, central nervous system and breast cancers [50, 161] . Colchicine shows toxicities and therefore is not recommended for the treatment of cancer disease. In recent years, Gloriosa superba in tropical regions reported to be vital source of colchicine [161] .
Ellipticine
Ellipticine (topoisomeraseⅡinhibitor) along with elliptine (now isoreserpiline) is also naturally occurring anticancer compound extracted from the stem, bark, leaf and root of Bleekeria vitensis and Ochrosia elliptica. These alkaloids are also found in Aspidosperma, Ochrosia, and several Apocynaceae members. The most significant DNA-damaging mechanisms of ellipticine [26] Curcuma longa Zingiberaceae Rhizomes Curcumin, ascorbic acid Leukemia, glioblastoma and colon cancer (In vitro) [27] Allium wallichii Amaryllidaceae Whole plant Steroids, terpenoids, flavonoids, reducing sugars and glycosides Prostate cancer, breast cancer, cervical cancer (In vitro) [28] Artemisia annua Asteraceae Whole plant Artemisinin Liver, breast and pancreatic cancer (Both in vitro and in vivo) [29] Debregeasia saeneb Urticaceae Stem Tannins Internal tumors (In vitro) [25] Camelia sinesis Theaceae Leaves Epicatechingallate, picatechin, epigallocatechin Lung, bladder, skin, prostate and breast cancer (Both in vitro and in vivo) [30] Paeonia suffruticosa Paeoniaceae Seed Polysaccharides (HBSS, CHSS, DASS, and CASS)
Prostate, colon, human breast, and cervical cancer (In vitro) [3] Ocimum sanctum Lamiaceae Leaves Eugenol, orientin, vicenin
Breast, liver and fibrosarcoma cancer (In vitro) [31] Ginkgo biloba Ginkgoaceae Leaves Ginkgetin, ginkgolide A & B
Hepatocarcinoma, ovary, prostate, colon and liver cancer [32] Camellia sinensis Theaceae Leaves Theabrownin Lung cancer (In vivo) [33] Ziziphus mauritiana Rhamnaceae Leaves, bark, fruit a-linolenic acid, Methyl stearate Leukemia, human cervical and liver cancer (In vitro) [34] Solanum nigrum Solanaceae Leaves Solamargine, solasonine Breast, liver, lung and skin cancer (In vitro) [35] Vigna unguiculata Fabaceae Seeds Black-eyed-pea trypsin/ Chymotrypsin inhibitor Human breast cancer (In vitro) [36] Ziziphus spina-christi Rhamnaceae Flowers, leaves Doxorubicin, spinanine-A, rutnine, quercetin
Lung cancer and breast cancer (In vivo) [37] Glycyrrhiza glabra Leguminosae Roots Licochalcone-A, licoagrochalcone
Prostate, breast, lung, stomach and kidney cancer (In vivo) [38] Herba epimedii Berberidaceae Leaves Icariin, icaritin, icariside Ⅱ Prostate, lung, kidney and gastric cancer (Both in vitro and in vivo) [39] Elusine coracana Poaceae Seeds Ragi bifunctional inhibitor
Myeloid leukemia cell and K562 cell line (Both in vitro and in vivo) [40] Psoralea corylifolia Leguminosae Seeds Psoralidin Stomach and prostate cancer [41] Peltophorum dubium Fabaceae Seeds Peltophorum dubium trypsin inhibitor
Rat lymphoma cells, human leukemia cells [42] Vicia faba Fabaceae Seeds Field bean protease inhibitors Skin cancer (Both in vitro and in vivo) [42] Xanthium strumarium Asteraceae Fruit Xanthatin Lymphocytic leukemia and liver cancer (In vitro) [43] Nigella sativa Ranunculaceae Seeds Thymoquinone Colon, prostate, breast and pancreas cancer [44] Ocimum sanctum Lamiaceae Leaves Eugenol, orientin, vicenin
Breast, liver and fibrosarcoma [31] Moringa oleifera Moringaceae Flowers, leaves Moringa oleifera protease inhibitor (MoPI)
Abdominal cancer (Both in vitro and in vivo) [40] Glycine max Fabaceae Seeds Bowman-Birk inhibitors Colorectal, prostate and colon cancer (Both in vitro and in vivo) [40] Bauhinia variegata Fabaceae Flower Kaempferol galactoside Breast, lung and liver cancer (In vivo) [44] Withania somnifera Solanaceae Roots Withaferin A, D Breast, cervix, prostate and colon cancer (In vivo) [45] Aegle marmelos Rutaceae Bark, root Lupeol Lymphoma, melanoma, leukemia and breast cancer (In vitro) [46] Zingiber officinale Zingiberaceae Ginger Gingerol Ovary, cervix, colon, liver and urinary caner (In vitro and in vivo) [47] Sylibum marianum Asteraceae Flower, leaves Silibinin Lung, liver, skin, colon and prostate cancer (Both in vitro and in vivo) [48] (continued on next page) [49] Colchicum autumnale Colchicaceae Leaves Colchicine Hodgkin's lymphoma, chronic granulocytic leukemia (Both in vitro and in vivo) [50] Aegle marmelos Rutaceae Stem bark Skimmianine Liver cancer (Both in vitro and in vivo) [51] Boswellia serrata Burseraceae Gum Boswellic acid Prostate cancer (In vitro) [52] Sylibum marianum Asteraceae Leaves, flowers Silymarin Colorectal cancer and colon cancer (Both in vitro and in vivo) [53] Curcuma longa Zingiberaceae Dried rhizome Curcumin Colon adenocarcinoma (In vitro) [54] Alstonia scholaris Apocynacea Root bark O-methylmacralstonine, talcarpine,villalstonine, pleiocarpamine
Lung cancer (Both in vitro and in vivo) [55] Podophyllum peltatum Podophyllaceae Leaves Podophyllotoxin Non-small cell lung carcinoma (Both in vitro and in vivo) [56] Andrographis paniculata Acanthaceae Whole plant Andrographolide Colon cancer (Both in vitro and in vivo) [49] Ziziphus jujuba Rhamnaceae Fruits, seeds, leaves Linoleic acids, triterpenoids
Breast cancer, human Jurkat leukemia T cells (Both in vitro and in vivo) [57] Podophyllum hexandrum Berberidaceae Leaves Podophyllotoxin Breast, ovary, lung, liver, bladder and testis cancer (In vitro) [58] Betula utilis Betulaceae Bark Betulinic acid Melanomas (In vitro) [59] Panax ginseng Araliaceae Roots Panaxadiol Human colon cancer (Both in vitro and in vivo) [60] Panax pseudoginseng Araliaceae Roots Panaxadiol Human colon cancer (Both in vitro and in vivo) [60] Gossypium hirsutum Malvaceae Cotton Gossypol Mice xenograft (HT-29) and colorectal cancer (Both in vitro and in vivo) [61] Passiflora caerulea Passifloraceae Flower Chrysin Colorectal cancer (in vitro) [62] Plumbago zeylanica Plumbaginaceae Leaves Plumbagin Liver, fibrosarcoma, leukemia and breast cancer (In vitro) [63] Capsicum annuum Solanaceae Pepper Luteolin Colorectal cancer (Both in vitro and in vivo) [49] Zingiber officinale Zingiberaceae Rhizomes 6-Shogaol Ovary cancer (In vitro) [64] Curcuma longa Zingiberaceae Root, rhizome Curcumin Breast, lung, colon, prostate esophagus, liver and skin cancer (In vitro) [65] Oldenlandia diffusa Rubiaceae Stem bark, leaves, fruit peel Ursolic acid Lungs, ovary, uterus, stomach, liver, colon, rectum and brain cancer (Both in vitro and in vivo) [66] Zingiber officinale Zingiberaceae Ginger 6-Shogaol Ovary cancer (in vitro) [64] Zingiber officinale Zingiberaceae Root Gingerol Colon, breast and ovarian cancer (Both in vitro and in vivo) [47] Broussonetia papyrifera Moraceae Fruits, leaf, bark 2S-abyssinone Ⅱverubulin Glioblastoma and brain cancer (In vitro) [67] Glycyrrhiza uralensis Fabaceae Roots Isoliquiritigenin Human lung cancer (In vitro) [68] Boerrhavia diffusa Nyctaginaceae Roots Punarnavine Malignant melanoma cancer (In vitro) [69] Vitis vinifera Vitaceae Seeds extract Procyanidins Human colon cancer (In vitro) [70] Polygonum cuspidatum Polygonaceae Whole plant Resveratrol Colorectal, skin and liver cancer (In vitro) [71] Morinda citrifolia Rubiaceae Roots Damnacanthal Lung cancer, sarcomas (In vitro) [72] Biophytum sensitivum Oxalidaceae Fruits and berries Alcoholic extract Dalton's lymphoma ascites, Ehrlich ascites carcinoma (In vitro) [73] Gossypium hirsutum Malvaceae Whole plant Gossypol Breast, stomach, liver, prostate and bladder cancer (In vitro) [74] Aloe vera Asphodelaceae Leaves Alexin B, emodin Leukemia, stomach cancer (In vivo) [75] Vaccinium macrocarpon [77] Argemone gracilenta Papaveraceae Whole plant Argemonine and berberine B-cell lymphoma, leukemia (In vitro) [78] Psoralea corylifolia Leguminosae Seeds Bavachanin, corylfolinin, psoralen Lung, osteosarcoma, fibrosarcoma and liver cancer (In vitro) [79] Moringa oliefera Moringaceae Leaves Niazinine A Blood cancer (In vitro) [80] Amoora rohituka Meliaceae Stem bark Amooranin Lymphocytic leukemia (In vitro) [81] Conyza Canadensis Asteraceae Roots Conyzapyranone A and B
Epidermoid carcinoma (In vitro) [82] Ziziphus rugosa Rhamnaceae Pericarp and seed Betulinic acid Cytotoxicity against human melanoma cells (In vivo) [83] Panax ginseng Araliaceae Leaves Panaxadiol, panaxatriol Breast, ovary, lung, prostate and colon cancer (In vitro) [84] C. roseus Apocynaceae Leaves Vinblastine, Vincristine Breast, ovary, cervix, lung, rectum and testis cancer (In vitro) [85] Centella asiatica Apiaceae Leaves Asiatic acid Melanoma, glioblastoma, breast (In vivo) [86] Viscum album Santalaceae Sprouts Viscumin, digallic acid Breast, cervix, ovary, stomach, colon, kidney, lung cancer (Both in vitro and in vivo) [87] Leea indica Vitaceae Leaves Gallic acid Ehrlich ascites carcinoma (In vitro and in vivo) [88] Liriodendron tulipifera Magnoliaceae Stem Costunolide, tulipinolide, liriodenine, germacranolide KB (Oral cancer), HT29 cell line (Both in vitro and in vivo) [89] Viscum album Santalaceae Fruits Viscumin, digallic acid Breast, ovary, lung, kidney, bladder and testis cancer (In vitro) [87] Cicer arietinum Fabaceae Seeds Bowman-Birk-type protease Breast and prostate cancer (In vitro) [90] Crocus sativus Liliaceae Dry stigmas Crocetin Hippocampal cell death and lung cancer (In vivo) [91] Centella asiatica Apiaceae Leaves Asiatic acid Melanoma, glioblastoma and breast cancer (In vivo) [92] Tylophora indica Asclepiadaceae Leaves Tylophorine Breast cancer (In vivo) [93] Dioscorea colletti Dioscoreales Rhizomes Dioscin Liver and human gastric cancer (In vitro) [94] Croton macrobotrys Euphorbiaceae Leaves Corydine, salutaridine Leukemia and lung cancer (In vitro) [95] Clausena lansium Rutaceae Seeds Clausenalansamid A and B Gastric, liver cancer (In vitro) [96] Bleekeria vitensis Apocynaceae Leaf Elliptinium Myelogenous leukemia and breast cancer (In vivo) [97] Combretum caffrum Combretaeae Bark, kernal and fruit Combretastatins Colon, and leukemia and lung cancer (In vivo) [97] Solanum lycopersicum Solanaceae Fruit Lycopene Prostate and colon cancer (In vivo) [98] Plumbago zeylanica Plumbaginacea Roots Plumbagin Blood and skin cancer (In vitro) [99] Crocus sativus Iridaceae Flower stigmas Crocin, picrocrocin, crocetin, and safranal Sarcoma and oral cancer (Both in vitro and in vivo) [100] Actaea racemosa Ranunculaceae Rhizomes, roots Actein Liver and breast cancer (In vivo) [101] Peristrophe bicalyculata Acanthaceae Aerial parts b-Caryophyllene, azingiberene Breast cancer (In vitro) [102] Cannabis sativa Cannabinaceae Leaf Cannabinoid Lung, pancreas, breast, prostate and colorectal cancer (Both in vitro and in vivo) [103] Sylibum marianum Asteraceae Flower, leaves Silymarin Colorectal cancer (Both in vitro and in vivo) [104] Enterolobium contortisiliquum Fabaceae Seeds Enterolobium contortisiliquum trypsin inhibitor Gastric and breast cancer (Both in vitro and in vivo) [105] Linum usitatissimum Linaceae Leaves, flowers Cynogenetic glycosides Breast cancer (In vitro) [106] Calvatia caelata Agaricaceae Fruiting bodies Laccases (Enzymes) Liver, breast cancer (In vitro) [107] Tylophora indica Combretaeae Bark, Kernel fruit Tylophorine Breast cancer (In vivo) [97] Allium sativum Amaryllidaceae Buds, leaves Allylmercaptocysteine, allicin Lymphoma, cervix cancer (In vivo) [108] (continued on next page) [109] Plumbago zeylanica Plumbaginaceae Roots Plumbagin Blood cancer, skin cancers (In vitro) [99] Saffron crocus Iridaceae Dry stigmas Saffron Liver, lung cancer and pancreatic cancer (In vitro) [110] Taxus brevifolia Taxaceae Bark nab-Paclitaxel Ovarian and breast cancer (Both in vitro and in vivo) [23] Vitis vinifera Vitaceae Fruit Cyanidin Colon cancer (In vivo) [111] Actaea racemosa Ranunculaceae Rhizomes and roots Actein Liver and breast cancer (In vivo) [101] Pyrus malus Rosaceae Bark, fruit Quercetin, procyanidin Colon cancer (Both in vitro and in vivo) [112] Betula Sp. Betulaceae Leaves Betulinic acid Human melanoma xenografts and leukemia (In vitro) [113] Tabernaemontana divaricata Apocynaceae Leaves Cononitarine B, Conophylline
Liver, lung, breast and colon cancer (In vitro) [114] Smilax chinensis Liliaceae Rhizomes Tannin, saponins and flavonoid Sarcoma-180 and ascites sarcoma (Both in vitro and in vivo) [112] Allium sativum Liliaceae Whole plant Allin Carcinoma of human (mammary) gland (Both in vitro and in vivo) [115] Aloe vera Liliaceae Whole plant Aloesin, emodin Anti-angiogenic activity (In vitro) [116] Curcuma longa Zinziberaceae Roots Curcumin Stomach cancer (In vitro) [117] Emblica officinalis Euphorbiaceae Polyphenols, tannins Lymphoma and melanoma (In vitro) [118] Momordica charantia Cucurbitaceae Leaves, Roots Charantin, cucurbitanetype triterpene
Colon cancer and breast cancer (In vitro) [119] Stevia rebaudiana Asteraceae Leaves Labdane sclareol properties Anti-tumorous and cytotoxic (In vitro) [120] Camellia sinensis Theaceae Leaves Epigallocatechin gallate Brain, prostate, cervical and bladder cancer (In vivo) [121] Nelumbo nucifera Nelumbonaceae Embryos Neferine Liver cancer (In vitro) [122] Ocimum sanctum Lamiaceae Leaves Caryophyllene, camphor Ssarcoma-180 solid tumor (In vitro) [11] Calvatia caelata Agaricaceae Fruiting bodies Calcaelin Breast and spleen cancer cells (In vivo) [123] Pleurotus sajor-caju Agaricaceae Fruiting bodies Ribonucleases Leukemia and liver cancer (in vivo) [124] Lentinus edodes Marasmiaceae Fruiting bodies Lentinan Sarcoma-180 in mice (In vivo) [124] Schizophyllum commune Schizophyllaceae Fruiting bodies Schizophyllan Head and neck cancer (In vivo) [125] Matricaria chamomilla Asteraceae Whole plant Apigenin Colorectal cancer (in vivo) [126] Fagopyrum sculentum Polygonaceae Seeds Buckwheat inhibitor-1 protein T-acute lymphoblastic leukemia (T-ALL) cells (in vitro) [127] Glycine max Fabaceae Seeds Soybean trypsin inhibitor Human ovarian cancer (in vivo) [128] Ipomoea batata Convolvulaceae Roots Trypsin inhibitor protein Promyelocytic leukemia cells (In vitro and in vivo) [129] Lavatera cashmeriana Malvaceae Seeds Lavatera cashmeriana protease inhibitors (LCpi Ⅰ, Ⅱ,Ⅲ)
Leukemia, lung, colon cancer (In vitro) [130] Lens culinaris Fabaceae Seeds Lentil (Lens culinaris trypsin inhibitor)
Human colon cancer (Both in vitro and in vivo) [131] Medicago scutellata Fabaceae Seeds Medicago scutellata trypsin inhibitor
Human breast and cervical cancer (In vitro) [132] Phaseolus acutifolius Fabaceae Seeds Tepary bean protease inhibitor Leukemia L1210 and lymphoma MBL2 (In vitro) [133] Pisum sativum Fabaceae Pea Protease inhibitors, rTI1B, rTI2B
Human colorectal and colon cancer (In vitro) [134] Phaseolus vulgaris Fabaceae Seeds Tepary bean protease inhibitor Leukemia L1210 and lymphoma MBL2 (In vitro) [133] Coccinia grandis Cucurbitaceae Leaves (CG) protease inhibitors Colon cancer (In vitro) [135] Ginkgo biloba Ginkgoaceae Leaves EGb and bilobalide Colon cancer (In vivo) [136] Curcuma zedoaria Zingiberaceae Whole plant Curcumin Colorectal cancer and B-16 melanoma cells (In vitro) [137] Clematis manshrica Ranunculaceae Flower, Leaves 1,4-benzoquinone,5-oethyl-embelin, 15-carbon isoprenoid
Liver cancer and blood cancer (In vivo) [ 
138]
Javed
were considered to be topoisomerase II inhibition and intercalation with DNA in order to avoid proliferation [171] . Ellipticine and their derivatives e.g. N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride, 2-N-methyl 9-hydroxyellipticine are efficient anticancer compounds and are used to cure ependymoblastoma, leukemia, myeloma, melanoma, breast and colon cancer [172, 173] . Ellipticine also perform their functions by inhibiting p53 protein phosphorylation and inhibit CDK2 kinase in human lung and colon cancer. A derivative of ellipticine (elliptinium) is also in clinical trials in France to check out its anticancer potential against breast cancer [174] .
Berberine
Berberine is a strong anticancer compound in terms of its efficacy and clinical trials isolated from the root and rhizome of Tinospora cordifolia, Berberis vulgaris, Berberis aquifolium and Rhizoma coptidis [175] . Berberine has been used for the treat of variety of cancers namely; breast, prostate and colorectal cancer [176] . Berberine induces apoptosis and cell cycle arrest at G 2 /M phase in breast, colorectal and liver cancer, inhibit anti-apoptotic proteins c-IAP1and Bcl-2, activate pro-apoptotic proteins (p21, p53, caspase-3 and caspase-9) [177] . The molecular targets of berberine are illustrated in Figure 2. 
Combretastatins
The combretastatins is a class of anti-angiogenic agents isolated from Combretum caffrum (Combretaeae) and specifically suppresses tumor angiogenesis. For this purpose, National Cancer Institute has collaborated with botanical Research Institute of South Africa and developed novel anticancer agent combretastatins and many derivatives. Combretastatinn of family Stilbenes act against tumor and causes tumor necrosis due to [139] Withania somnifera Solanaceae Root stem and leaves Adriamycin and 5-fluorouracil
Human cervical cancer cell (In vitro) [140] Aristolochia fontanesii Aristolochiaceae Roots Aqueous extract Breast cancer (In vitro) [141] Centella asiatica Apiaceae Whole plant Asiatic acid, Tamoxifen Breast cancer (In vitro) [142] Carissa spinarum Apocynaceae Fruit Alkaloids, saponins, tannins, flavonoids Nasopharyngeal carcinoma (In vitro) [143] Asclepias curassavica Asclepiadaceae Aerial pats Asclepin, cardenolides Liver cancer (In vitro) [144] Annona squamosa Annonaceae Seed Bullatacin Liver cancer (In vitro) [145] Bryophyllum pinnatum Crassulaceae Leaves Bryophyllin A Cervical cancer (In vitro) [146] Butea monosperma Fabaceae Flower Butrin, (7,3
Liver cancer (In vitro and in vivo) [147] Vitex negundo Lamiaceae Fruit Chrysoplenetin Human pancreatic cancer (In vitro) [148] Moringa oleifera Moringaceae Seed Pterygospermin 4-(4 0 -Oacetyl-a-Lrhamnopyranosyloxy), benzylisothiocyanate,4-benzylisothiocyanate Lung, neuroblastima and colon cancer (In vitro) [149] Syzygium cumini Myrtaceae Fruit Kaempferol-7-Omethylether, g-sitosterol Leukemia (In vitro) [150] Argemone mexicana
Gall bladder and breast cancer (In vivo) [151] Citrus limon Rutaceae Fruits 5-hydroxy-6,7,8,3 0 ,4 0 -pentamethoxyflavone Human colon cancer (In vitro) [152] Taxus wallichiana Taxaceae Stem bark Diterpenoid 2-deacetoxytaxinine Breast and kidney cancer (Both in vitro and in vivo) [153] Berberis vulgaris Berberidaceae Roots stem and bark Berberine Breast, liver, colon cancers (In vitro) [154] C. roseus Apocynaceae Bark, leaves Vindesine Leukemias, testicular, breast and lung cancer (In vitro) [113] C. roseus Apocynaceae Bark, leaves Vincristine Lymphocytic leukemia (In vivo) [113] C. roseus Apocynaceae Bark, leaves Vinblastine Lymphocytic leukemia (In vivo) [113] T. baccata Taxaceae Bark, leaves Cabazitaxel Prostate cancer (In vivo) [154] Colchicum autumnale Colchicaceae Leaves Colchicine Multiple solid tumors (In vitro and in vivo) [155] T. baccata Taxaceae Bark, leaves Larotaxel Breast, bladder and pancreatic cancer (In vivo) [156] Taxus brevifolia Taxaceae Bark Paclitaxel Breast and ovarian cancer (In vivo) [113] Berberis vulgaris Berberidaceae Root, stem bark Berberine, cannabisin Breast, prostate and liver cancer (In vivo) [ 
157]
Javed Iqbal et al./Asian Pac J Trop Biomed 2017; 7(12): 1129-1150 its antiangiogenic property. Combretastatins (A-4 CA4) is a water soluble analog and is effective against leukemia, lung cancer and colon cancers [97] . The different parts of Indian medicinal plant Terminalia bellerica (Combretaceae) fruit, kernel and bark are used in isolation of active combretastatins compounds with strong anticancer properties [16, 97] . This agent is presently under research to cure medullary thyroid and anaplastic thyroid cancer [178] .
Triterpenoid acids
Triterpenoid acids are also naturally occurring phytomolecules with anticancer properties. Moreover, these potent anticancer agents have shown strong anticancer results in both invitro and in-vivo against leukemia, pancreatic and breast cancer. Other anticancer agents like, CDDO (2-cyano-3, 12-dioxoolean1, 9-dien-28-oic acid) and its methyl ester are active against ovarian cancer [113] . Betulinic acid is another triterpenoid isolated from Ziziphus mauritiana, Ziziphusrugosa and Ziziphus oenoplia and Betula Sp. (Betulaceae) and is cytotoxic against a wide range of cancer including human melanoma [179] . 
Capsaicin
Capsaicin is also a natural phytochemical isolated from red pepper and exert strong anticancer, antimutagenic, antimetastatic, anti-angiogenic and chemopreventive functions in pancreatic, prostatic, liver, skin, leukemia, lung, bladder, colon, and endothelial cells [180, 181] . Capsaicin regulate different molecular targets in breast cancer like, caspase-3, reactive oxygen species (ROS), Rac1, and HER-2 etc. [182] . Capsaicin is more potent by inducing apoptosis in the presence of p53 gene product (p53 known as the 'Grandfather of the genome' in terms of care) [183] . Capsaicin produced apoptosis in breast cancer (H-Ras, MCF10A cells) by inducing ROS and Rac1 signaling pathways. These ROS and Rac1 pathways are specifically induced by proteins like, p38, c-Jun N-terminal protein kinase-1 [184] .
Flavones/Flavonoids
Flavonoids are also plant-specific secondary metabolites with around 8 000 diverse compounds largely distributed in fruits, grains, tea, vegetables, soybean and play a vital role for the treatment of large number of cancer [110] . Freeze-dried berries rich in anthocyanins have been studied for anti-cancer potential against oral lesions [185] , familial adenomatous polyposis [186] , and esophageal dysplastic lesions [187] . Flavopiridol is a plantderived semisynthetic flavone that inhibit cyclin-dependent kinase with anticancer activity against esophageal and gastric cancers [188] . To date, meta-analyses have primarily focused on the functions of dietary flavonoids including inhibition of DNA topoisomerase I, and cycloxigenase and are used against breast [189] , lung [190] , stomach and colorectal cancer [191] . Flavopiridol and its mechanism of action on different enzymes are given in Figure 1 .
Cyanidin glycosides
Cyanidin is an organic compound isolated from apples, grapes, plums, blackberry, raspberry, red berries, cranberry, red onion and red cabbage with multiple biological functions as for e.g., antioxidant, radical scavenging effects, inhibit cell groth and division through COX-2 and iNOS gene expression in colon cancer cells [192] . Cyanidin-3-orutinoside, cyanidin-3-O-glucoside and freeze-dried black raspberries selectively inhibit cell growth and induced apoptosis in a highly tumorigenic rat esophagus RE-149 DHD cell line [192] . Cyanidin glycosides from red berries perform functions of anticancer via many mechanisms. It stops the synthesis of COX-2 enzyme in colon cancer, induces apoptosis in prostate cancer, stops MMP-9 expression in bladder and lung cancer [193] . Stops the Erk phosphorylation and MMP-2 and MMP-9 in fibrosarcoma cells, suppresses expressions of Jun N-terminal kinases (JNK), MMP-9 and Erk enzymes in gastric cancer (stomach cancer) [194] . Cyanidin and its nuclear and cellular targets are summarized in Figure 1. 
Saffron (Crocetin)
Crocus sativus L. commonly known as Saffron, rich in potent anticancer compound carotenoids, crocin, crocetin and safranal [67] . Saffron is marked as a promising agent for a novel anticancer drug against human lung, liver, skin, pancreatic, colorectal and breast cancer by regulating different nuclear and cellular factors, inhibiting iNOS, COX-2 enzymes, reduced serum level IL-b, TNF-a, cyclin B, cyclinA and cdk2, upregulate Bax/Bcl-2 ratio, regulate of caspase-3, 8 and 9 expression, down-regulate MMP-2, MMP-9 expression, induces apoptosis, targets microtubules and inhibit invasion and metastasis [91, 195] .
Epigallocatechin gallate
The main polyphenolic constituent of green tea called epigallocatechin possess the ability to restore genes expression of tumor suppression such as retinoid X receptor alpha, results in breast cancer inhibition by binding to many high affinity target proteins such as, 70 kDa zeta-associated protein (Zap-70) [196] . Molecular docking studies confirmed that both PI3K and mTOR signaling pathways binds well to the PI3K kinase domain active site displaying ATP-competitive activity in MDA-MB-231 and cervical cancer [197] , brain cancer [198] and bladder cancer [199] .
Gingerol
Gingerol is also a group of bioactive compound isolated from the fresh rhizome of Zingiber officinale containing [6] -gingerol, [8] -gingerol and [10] -gingerol with marked anticancer properties in colon, pancreas, ovarian and breast cancers. It downregulates the expression of iNOS and TNF-alpha through suppressing NF-kB nuclear translocation and IkBa phosphorylation [200, 201] . Oyagbemi et al. summarized the mechanisms of action of gingerol onK562 cells, MOLT4 cells with high reactive oxygen species, induced apoptosis in leukemia cells by mitochondrial pathway [201] . [10] -gingerol has strong anticancer potential than that of [6] -gingerol and [8] -gingerol and have shown promising results for the treatment of MDA-MB-231 and MDA-MB-468 breast cancer. The inhibitory effect of [10] -gingerol on MDA-MB-231 cells was related with the reduction of number of cell divisions, cell cycle arrest, induces apoptosis and releases proapoptotic mitochondrial cytochrome c [202] . Gingerol mechanism of action on different molecular targets is given in Figure 1. 
Lycopene
Lycopene is a bright red pigment with anticancer potential isolated from tomatoes, watermelons, red papayas and red carrots and plays significant role in targeting PI3K/Akt signaling pathway in pancreatic and stomach cancer by down-regulating Erk and Bcl-2 proteins [165] . It up-regulates anti-oxidant enzymes (GSH, GST and GPxn) and removes oxidative damage caused by the carcinogens in breast, endometrial, prostate and colon cancer [203] . HT-29 colorectal cancer cells and animal models have shown that lycopene has also effect on cell proliferation and progression by interacting with various cellular signaling pathways like, NF-kB and JNK [204] . Lycopene also inhibited invasion, metastasis and proliferation in human SW480 colorectal cancer cells by restraining NF-kB and JNK activation, causes inflammation and suppresses the expression of COX-2, iNOS IL-1b, IL-6, and TNF-a [205] . Lycopene and its different nuclear and cellular targets are given in Figure 2. 
Vitamin D from mushroom
Mushrooms exposed to light like vertebrates serve a better source for vitamin D after exposure to ultraviolet B light. Light exposed mushrooms vitamin D has been involved in therapy of wide range of cancer including colon cancer [206] , breast cancer [207] pancreatic_ENREF_105 and ovarian cancer by targeting different proteins, enzymes and signaling pathways, prevents carcinogenesis, metastasis and induces apoptosis [208] .
Polysaccharides from mushrooms
Biologically active polysaccharides have been detected in fruiting bodies and mycelial mass of Macromycetes. Mushroom polysaccharides prevent carcinogenesis and display immune cellmediated anticancer potentials [209] . Polysaccharides with antitumor functions like glucans, lentinan, tegafur, tegafur in combination with lentinan, and schizophyllan have been used for the treatment of lung, breast, and gastric cancers, enhance cellular immunity in the tumor cell, induce apoptosis, prevent invasion and metastasis, act as a macrophage activator, T-cell adjuvant, induce gene expression of cytokines and increase patient's survival with head and neck cancers [210] . Mushrooms polysaccharides and its molecular targets are given in Figure 2. 
Dietary fibers from mushrooms
Mushrooms dietary fibers are also used as strong anticancer agents against different kind of cancers targeting different molecular pathways. Mushroom cell walls contain high molecular weight materials which cannot be digested and absorbed by human intestine, but can absorb carcinogenic substances (heavy metals and free radicals etc.), chitin, homo-and heteropolysaccharides and in this way these high molecular weight materials have been proven as strong anticancer agent against a variety of cancers [211] .
Proteins from mushroom
Mushroom proteins are one of the most extensively studied bioactive substances of mushrooms with their pharmaceutical potential and protein engineering. Many potent anticancer agents such as lectins, bolesatine, hemolysins, phallolysin, nebrodeolysin, laccases, calcaelin and ribonucleases have been isolated from different species of mushrooms (e.g., Polyporus adusta and Ganoderma carpense, Pleurotus ostreatus, Pleurotus eryngii, Pleurotus nebrodensis, Amanita phalloides and Calvatia caelata etc.) and are used to treat a variety of cancers including lung cancer [212, 213] . Ganoderma lucidum extracts can significantly inhibited the release of MMP-2, MMP-9, IL-6 and IL-8 in triple negative breast cancer cells [214] . In the past several chemical compounds extracted from mushroom possessed anticancer properties such as polysaccharopeptide significantly increased the ratio of CD4 + /CD8 + /CD14 + /CD16, T lymphocytes, increase the quantity and percentage of the B lymphocytes and CVP, induce apoptosis and cell cycle arrest [215] .
Vitamin E from plant oil
Vitamin E has been reported as anti-tumor agent and represents a group of compounds consisting of both tocotrienols and tocopherols. It is fat-soluble anti-oxidant present in sunflower oil, germ oil, safflower oils and wheat. It has been researched that both tocopherols and tocotrienols exhibit antitumor properties like proapoptotic, anti-proliferative effects in both either in-vitro and in-vivo studies [216] .
Fisetin
Fisetin is an active flavone found in various plant species such as strawberries, apple, grape and onion. It has been examined for its potential anticancer consequences; these are anti-migration and anti-proliferation, apoptosis effects on human colon cancer [111, 217] . Fisetin is also used to treat human lung cancer by displaying dual inhibition of PI3K/Akt signaling pathways [218] . Moreover, it has anticancer effects in a wide range of cancer cells. For instance, fisetin found to induce apoptosis through inhibition of MAPK signaling network in human lung cancer and reactive oxygen species production in human oral cancer. It also induces apoptosis in human renal carcinoma caki cells via p53-mediated up-regulation of DR5 expression [219] . The mechanisms of action of fisetin on different signaling pathways are given in Figure 1. 
Resveratrol
Resveratrol is also a naturally occurring polyphenol and has been identified in mulberries, peanuts, grapes, bilberries and blueberries. Resveratrol play substantial role in curing a wide range of cancers including breast, colorectal, liver, pancreatic, prostate cancer and lung carcinoma by up-regulating p53 and Bcl-2 associated X proteins and down-regulating MMPs, NFkB, AP-1, Bcl-2, cyclins, cyclin dependent kinases, cytokines, and COX-2 proteins [220, 221] . Resveratrol is known to inhibit angiogenesis, suppressing VEGF protein action by reducing MAP kinase phosphorylation [222] . The mechanism of action of resveratrol on different nuclear and cellular factors are given in Figure 1. 
Anticancer compounds from algae
More than 50% of the marine blue-green algae are largely used for the isolation of anticancer compounds which are effective in either inducing apoptosis or triggering signaling pathways through activation of protein kinase-c enzymes, NF-kB, MAPK kinases, p53, cytokines release and ROS production. The cell extracts of Calothrix [Calothrixin A (I) and B (II), Lyngbya majuscule (Curacin-A)] are strong antiproliferative agents with inhibitory role in colon, renal and breast cancers [97] . Similarly, cryptophycin 1 isolated from a species of Nostoc (GSV 224) revealed strong cytotoxicity against human solid tumors. The compounds isolated from edible seaweed like Padina boergeseni, Ulva reticulata, Gracilaria foliifera, Palmaria palmate, Acanthaphora spicifera, Sargassum thunbergii, Ascophyllum nodosum and Eclonia cava have also shown marked anticancer activities and are used to treat kidney cancer, ammary adenocarcinoma, colon adenocarcinoma, human nasopharyngeal and colorectal cancer [223, 224] . Cyanobacterium (e.g. Spirulina platensis) is effective against different types of human cancers (liver, lung, stomach and breast cancer via the production of valuable products (phycobiliproteins including cphycocyanin, phycocyanobilin, allophycocyanin) [225] .
Apigenin
Apigenin (APG) is a naturally occurring flavonoid identified in the different fruits and vegetables such as celery, chamomile and parsley with features including low toxicity and non-mutagenic, induces apoptosis and targets leptin/leptin receptor pathway in lung cancer. Apigenin also activates caspase dependent extrinsic apoptosis pathway, inhibit signal transducer and activator of transcription 3 (STAT3) signaling pathways [226, 227] . APG is also used to treat MDA-MB-453 breast cancer through inhibiting STAT3 signaling pathway by expression levels of caspase-3, caspase-8, induces extrinsic apoptosis, blocking the phosphorylation of JAK2 and STAT3 pathways [226] . Detailed information about apigenin regulating different protein, enzymes and signaling pathway are given in Figure 1 and 2. 
Curcumin
Curcumin is also a lead phytochemical extracted from Curcuma longa with inhibitory property over the growth of human glioblastoma cells by modulating several nuclear and cellular factors, upregulates the expressions of different genes and their products [p16, p21 and p53 (These genes are also called as 'Grandfather of the genome' in terms of care for the cell], Bcl-2 associated X protein (Bax protein), EIK-1 (ETS oncogenic family), extracellular signal regulated kinase (Erk enzyme), early growth response protein 1, c-Jun N-terminal kinase, and caspase enzymes 8, 9) and decreases the level of Bcl-2, mTOR, p65, protein kinase B (Akt), retinoblastoma protein (pRB), NF-kB, and cyclin D1 proteins [54] . Detailed information about curcumin and its mechanism of action on different proteins and signaling cascades are summarized in Figures 1  and 2. 3.27. b-elemene b-elemene a sesquiterpene, is a lso a promising anticancer agent with a wide range of its effect against drug-resistant tumors and has been isolated from Curcuma wenyujin [228] . belemene is major component of traditional Chinese medicine and inhibit different forms of cancer, induces apoptosis and cell death, inhibit the expression of VEGF, downregulates Akt phosphorylation and CD34 expression, suppressing PI3K/Akt/ mTOR, MAPK and pathway, attenuating angiogenesis and upregulates the E3 ubiquitin ligases, Cbl-b and c-Cbl in human gastric cancer [229, 230] . b-elemene molecular targets are given in Figure 2. 
Chalcone
Chalcone is also a naturally occurring anticancer flavonoid in fruits and vegetables. It is responsible for activation of different caspases (caspase-8, 9, 12 enzymes), upregulate the of proapoptotic proteins expression (Bid, Bax, and Bak proteins), decreases anti-apoptotic Bcl-2 gene expression and have been used for the treatment of the treatment of colon, lung, breast, liver and prostate cancer [231] . Chalcone targeted different nuclear and cellular factors (Bax, Bid, and Bak, Bcl-2 proteins, caspase-8, 9, 12 enzymes are illustrated in Figure 2. 
Sesquiterpene lactones
Sesquiterpene lactones constitute large and diverse group of bioactive compounds isolated from several plant families (e.g. Asteraceae) exhibiting cancer cell cytotoxicity and antineoplastic efficacy and are used for the treatment of a large number of cancer like, prostrate, liver, lung, breast esophageal cancer [232] .
Sesquiterpene lactone e.g deoxyelephantopin and isodeoxyelephantopin are components of Elephantopus carolinianus and Elephantopus scaber and have been shown to induce apoptosis via multiple mechanisms, comprised induces ROS, mitochondrial dysfunction, modulate Bcl-2 family protein, arrest cell cycle, inhibit NF-kB, and STAT3 activation [233] .
Chrysin
Chrysin [5,7-dihydroxyflavone] , is an effective anticancer compound showed less side effects and distributed in propolis, honey and blue passion flower, chamomile and possess strong antitumor effects on different cancer cell lines (DU145 and PC-3) [234, 235] . This flavone has also induced apoptosis in SW480 colorectal cancer, arrest cell cycle at G 2 /M phase, results in DNA cleavage and apoptosis, increasing ROS production and lipid peroxidation, suppressed the abundance of S6, AKT, PI3K, P90RSK and P70S6K, proteins, stimulate MAPK and ERK1/2 and P38 proteins in the prostate cancer cells [161, 236] . Chrysin and its mechanism of action on different targets are given in Figure 1. 
Scutellarin glycoside
Scutellarin is a promising anticancer agent isolated from medicinal plant species, Scutellaria barbata and Scutellariaaltissima and exhibits anti-tumor functions on different cancers for example, human colon cancer, liver cancer, and prostate cancer [237] . Scutellarin suppressed cancer cell proliferation, induces cell cycle arrest at G 2 /M phase, upregulating caspase-3, 9, and Bax/Bcl-2 ratio in prostate cancer [238] . Scutellarin also induced apoptosis in liver carcinoma (HepG2 cells) via STAT3 signaling cascade and caspase-3 enzyme activation [177] . In addition, this chemical agent also induces apoptosis in human colorectal cancer, inhibiting cell growth and induces apoptosis by regulating the p53 gene product [239] . The molecular targets of scutellarin are given in Figure 2. 
Oroxylin flavone
Oroxylin A is a potential flavone isolated from the Scutellariae radix down-regulate the expression of COX-2 and iNOS genes, block NF-kB, inhibit the activation of LPS-induced NF-kB by blocking IkB degradation [240] . Oroxylin A in combination with 5-FU is also used to treat colorectal cancer, exhibiting double action with COX-2 inhibition and increased ROS generation. Thus, oroxylin combination therapy could be a promising tool in order to reduce 5-FU doses and subsequent invivo side effects [241] . Oroxylin and its molecular targets are illustrated in Figure 2. 
Kaempferol
Kaempferol is also a naturally occurring anticancer agent isolated from propolis, black tea, grapefruit, broccoli. Kaempferol possess significant antitumor potential on a large number of cancer cells e.g. colorectal cancer and HT-29 cancer cells by activating the expression of caspase-3 enzyme, p53 gene and its products [242, 243] , arrest cell cycle at G 1 and G 2 /M phase by inhibiting the activity of different enzymes (CDK2, Cdc2 and CDK4) [244] . Kaempferol and its nuclear and cellular targets are illustrated in Figure 1. 
Genistein
Genistein is potent antitumor agent isolated from soybeans, lentils, beans and chickpeas. This isoflavone possessed proapoptotic function against colorectal cancer [245] . Genistein perform numerous functions as for example, up-regulate the expression of pro-apoptotic proteins (Bax and p21), inhibiting NF-kb and topoisomerase II enzymes [246, 247] , upregulate antioxidant enzyme expression such as glutathione peroxidase [248] . Genistein and its action on different protein, enzyme and signaling pathways are given in Figures 1 and 2. 
Silymarin
Silymarin is also naturally occurring flavolignan extracted from Sylibum marianum. This flavolignans mixture contained silydianin, silychrystin, silibinin (silybin A and B), and isosilybin (A and B), [249] . Silymarin induces cell cycle arrest and apoptosis by acting on cyclin dependent kinases and has been used together with paclitaxel and doxorubicin to treat colorectal cancer [250] .
Ursolic acid
The ursolic acid is triterpene is the main constituent in herbal species likewise rosemary and basil plants. This antioxidant compound play significant role in the modulation of cellular redox status of normal cells and exerts pro-oxidative action on tumor cells. It exhibits pro-apoptotic effects on colorectal cancer (HCT116 cell line) by reducing the level of pro-inflammatory NF-kB cytokine, survival effectors Bcl-2 and pro-metastatic MMP-9 matrix metalloprotease [251] . Ursolic acid and molecular mechanism of action on different nuclear and cellular targets are given in Figure 1. 
Ginsenosides
Ginsenosides constitue a class of active compounds responsible for pharmacological activities obtained from ginseng root. Preclinical and clinical researches demonstrated that ginsenosides have cancer preventing activities to various tumors, including liver, breast, gastric, ovarian, melanoma and colon cancer [252] . The six major ginsenosides (Rb1, Rb2, Rc, Rd, Re, and Rg1) constitute around 80% of the total ginsenosides in ginseng root and various minor ginsenosides [Rg3(S), Rh2(S), F2, compound K (C-K), Rg2(S), Rh1(S), F1, protopanaxatriol and gypenoside XVII] possess anti-invasion and anti-migration properties, induces apoptosis and cell cycle arrest [253] . Panaxadiol is a strong anticancer agent isolated from Panax ginseng and Panax pseudoginseng and has potent anti-cancer activity in different cancer cell lines and signaling pathways [254] . The same results were found with protopanaxadiol metabolite that significantly enhanced 5-FU effects on HCT116 cells by arresting cell cycle at G 1 phase and induces apoptosis [60] . One other member ginsenoside Rg3, is able to block NF-kB expression in HCT116 cell line leading to apoptosis [255] . Furthermore, ginsenoside-Rg5 is used to treat human cervical cancer by inducing apoptosis and cause DNA damage [256] .
Celastrol
Celastrol is also a strong anticancer compound in terms of its efficacy isolated from the bark of Tripterygium wilfordii and inhibits heat shock protein, blocking its interaction with Cdc37, apoptosis induction via caspase-3 enzyme in ovary (OVCAR-8), colon (SW620), lung 95-D and prostate cancer [257] . Celastrol also induces apoptosis and inhibit the expression of oncoprotein in acute myelogenous leukemia1-ETO/C-KIT [8, 21] [258]. It is also used to treat lung cancer cells through Hsp90 client protein degradation and caspases-dependent pathways [259] . Data from different cancers reports such as breast, lung, colon, prostate, esopharyngeal, glioblastoma, liver, skin, myeloma, pancreas, liver, leukemia, and gastric cancer) and animal models have suggested that celastrol induces apoptosis and cell cycle arrest, autophagy by the activation of ROS/c-JNK signaling pathway, inhibit angiogenesis and exhibit antiinvasive effect, upregulate death receptors in breast and colon cancer, activate Fas/Fas ligand pathway in lung cancer and inhibit PI3K/Akt/mTOR pathway in triple negative breast cancer [260] .
Gossypol
Gossypol is also a natural phytochemical found in cotton seeds (Gossypium) and Thespesia populnea, displays potential anti-cancer activities, has completed phase II clinical trials for treatment of human breast and prostate cancer. Its antitumor properties have been studied in a variety of tumors (lymphoid, hematologic and solid tumors). Gossypol suppresses cell proliferation, induces autophagy and apoptosis in colorectal cancer, HT-29, HCT116 and RKO cancer cell lines [61] .
Polysaccharides from plants
Plant polysaccharides are also promising anticancer agents and have long been used as theraphy for variety of cancers e.g. liver (HepG2 cells), lung (A549) cells, HL-60 cells, H157 cells, ovarian cancer, and human lymphatic endothelial cells [58] . Polysaccharides as anticancers agents haven been reported variously from medicinal plants [261] . Recently, researchers are shifting their research direction from microbe's polysaccharides to plant polysaccharides as they are non-toxic [262] . Many invitro and in-vivo studies indicated that these polysaccharides inhibit tumor cell proliferation by inducing cell cycle arrest and apoptosis in different type of cancers [66, 263] . There are numerous reports on the role of polysaccharides in inducing cell cycle arrest and apoptosis, regulate different signaling cascades and cell cycle genes and inhibit cancer cell proliferation in a wide range of cancer cell lines (HepG2 cells, A549 cells, human lymphatic endothelial cells and ovarian cancer [239, [264] [265] [266] .
Isothiocyanates
Isothiocyanates is a potent phytochemical occurs in vegetables belongs to family Crusiferae such as watercress and broccoli and are used for the treatment of different cancer namely, colorectal cancer, cervical cancer, lung cancer, prostate cancer, and human T-Leukemia cells without causing any toxic side effects [267] . These natural isothiocyanates can induce apoptosis and ROS-mediated mechanism, arresting cell cycle at G 2 /M phase, downregulate activated signaling cascades and modulate epigenetic changes, inhibit cell proliferation, progression and invasionmetastasis in colorectal and prostate cancer [268] . Sulforaphane, a dietary isothiocyanate possess anticancer property in cervical cancer cells via inducing G 2 /M arrest, downregulate cyclinB1 and up-regulate GADD45b proteins [269] .
Genipin
Genipin is a natural phytochemical isolated from Gardenia jasminoides and is used to treat breast cancer [270] . In breast cancer, genipin regulates different protein and enzymes as for examples, caspase-3, Bax, Bcl-2, JNK, p38, MAPK. Genipin has anti-proliferative activity in MDA-MB-231 breast cancer cells by down-regulating Bcl-2 expression and up-regulating Bax and caspase-3, pro-apoptotic signaling cascades such as JNK and p38 MAPK [271] .
Denbinobin
Denbinobin is another multifunctional phytochemical isolated from the stem of Ephemerantha lonchophylla and Dendrobium moniliforme with potent anti-cancer, anti-angiogenesis and apoptosis-inducing properties [272] . This compound inhibits metastasis by inhibiting Src kinase activity, decreases iNOS and COX-2 activity in concentration-dependent manner by suppressing NF-kB activation in human breast cancer cells [273] .
Different strategies for the development of anticancer phytochemicals
The potential of medicinal plants as therapeutic agents depends upon the quality and quantity of active phytochemicals in them, which vary with latitude, longitude, altitude, age, climate and season from species to species. Pharmacological functions and their level vary with plant parts. These bioactive phytomolecules can also be used in anticancer therapeutics but they still demand further research. The purification of active phytomolecules may involve various strategies such as combinatorial chemistry, isolation assays, and bioassay-guided fractionation. Bioassay guided fractionation with various analytical techniques could be used to separate various bioactive compounds from the mixture of compounds. The process begins with the natural extracts test (from dry/ wet plant material) with confirmed biological activity. Then, suitable matrices are used for the fractionation of active extracts, tested for bioactivity and various analytical techniques such as TLC, HPLC, FTIR, Mass spectroscopy and NMR etc. must be used for the separation of active fractions. For polarity order rise different solvents should to use. Superdex, Sephadex, Silica or any other suitable matrix can be used for fractionation. There are so many dyeing agents used for the detection of natural compounds in medicinal plants e.g. Vanillinesulfuric acid. These procedures Figure 5 . Detailed scheme of anticancer phytochemical synthesis, optimization, characterization and prospective use as cancer therapeutic agent.
could be change however purity, quality and quantity of the bioactive compounds should be high as much as possible and this can be achieved by using high quality of solvents, matrices and careful handling. After purification of these phytomolecules they must be examined for in-vitro or in-vivo anticancer effects. If a better anticancer property is achieved by the molecule then other aspects like pharmacokinetics, pharmacodynamics, immunogenicity, metabolic fate, biosafety and side effects, drug interactions, dose concentration etc. must be researched for future drug designing. Detailed scheme of bioactive compound synthesis, optimization, characterization, testing, and potential application as a cancer therapeutic agent is shown in Figure 5 .
Conclusions and future prospects
It has been evident from the present review that phytochemicals serve as promising and effective research area with bright future. The growing incidence of cancer and high cost, various limitations in the conventional therapy including high cost, and high toxicity of present anticancer drugs has faced a severe challenge to all the researchers to design and develop an alternative, eco-friendly, biocompatible and cost-effective strategy in a greener way. Under this scenario, phytomolecules are expected to revolutionize cancer treatment in the next decade. High biodegradability and biocompatibility have increased the efficacy of these phytomolecules in cancer therapy. This comprehensive review paper provides information on medicinal plants and their bioactive compounds with potential to cure different types of cancer. Potential anticancer phytochemicals described in this comprehensive review article should be further researched in clinical trials (Curcumin, epigallocatechin, isothiocyanates, gossypol, sulforaphane, garcinol, etc.) on different models for their effectiveness and toxicological documentation. Furthermore, extensive research work should be carried out on these phytochemicals to evaluate their possible applications, toxicological and particular genotoxic profile against a wide range of cancer in both either in-vitro or in-vivo.
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